Mouse aB crystallin 800bp promoter/AcGFP
(Plasmid
#98103)
-
PurposeMouse aB crystallin 800bp promoter segment driving GFP expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 98103 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAcGFP1-1
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 4100
- Total vector size (bp) 4942
-
Modifications to backboneNone
-
Vector typeGFP expressing
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAlpha B-crystallin promoter 800 bp fragment, Mus musculus
-
Alt nameMus Cryab
-
Alt nameCryab
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)833
-
GenBank IDCT010341
-
Entrez GeneCryab (a.k.a. Crya-2, Crya2, HspB5, P23)
- Promoter Alpha B-crystallin promoter 800 bp fragment (-833/-1)
-
Tag
/ Fusion Protein
- GFP (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Xho1 (not destroyed)
- 3′ cloning site BamH1 (not destroyed)
- 5′ sequencing primer TTCTTTCCTGCGTTATCC
- 3′ sequencing primer CCATTCACATCGCCATTCA (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Mouse aB crystallin 800bp promoter/AcGFP was a gift from Mason Posner (Addgene plasmid # 98103 ; http://n2t.net/addgene:98103 ; RRID:Addgene_98103) -
For your References section:
The zebrafish as a model system for analyzing mammalian and native alpha-crystallin promoter function. Posner M, Murray KL, McDonald MS, Eighinger H, Andrew B, Drossman A, Haley Z, Nussbaum J, David LL, Lampi KJ. PeerJ. 2017 Nov 27;5:e4093. doi: 10.7717/peerj.4093. eCollection 2017. 10.7717/peerj.4093 PubMed 29201567